EICHORCondition: Node-positive Breast Cancer · Sponsor: University Hospital, Basel, Switzerland
RATIONALE: The use of tailored axillary dissection as a tailored procedure will avoid surgical overtreatment by selectively removing the lymph nodes that are affected by the cancer, thereby sparing many women the unnecessary complications of a radical surgery, providing a better quality of life while keeping the same efficacy. PURPOSE: The phase III trial is evaluating the optimal treatment for breast cancer patients in terms of surgery and radiotherapy.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Walter Reed National Military Medical Center | Bethesda, Maryland, United States | — |
| Duke University/Duke Cancer Center | Durham, North Carolina, United States | — |
| Swedish Cancer Institute | Seattle, Washington, United States | — |
| Sanatorio Parque Breast Cancer Center | Rosario, Santa Fe Province, Argentina | — |
| Institute of Oncology "Angel H. Roffo | Buenos Aires, Argentina | — |
| Krankenhaus Dornbirn | Dornbirn, Austria | — |
| Landeskrankenhaus Feldkirch | Feldkirch, Austria | — |
| Medical University of Innsbruck, Department of Gynecology | Innsbruck, Austria | — |
| Ordens Kinikum Linz, Barmherzige Schwestern | Linz, Austria | — |
| Universitätsklinik für Frauenheilkunde und Geburtshilfe; Landeskrankenhaus Salzburg der PMU | Salzburg, Austria | — |
| Medizinische Universität Wien - Klinik für Chirurgie | Vienna, Austria | — |
| Medizinische Universität Wien - Universitätsklinik für Frauenheilkunde | Vienna, Austria | — |
+ 52 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03513614